Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s share price was up 3.1% during trading on Tuesday . The stock traded as high as $8.25 and last traded at $8.25. Approximately 500 shares were traded during trading, a decline of 18% from the average daily volume of 611 shares. The stock had previously closed at $8.00.
Oxford BioMedica Stock Up 3.1%
The company has a current ratio of 1.89, a quick ratio of 1.67 and a debt-to-equity ratio of 3.08. The firm has a 50-day simple moving average of $7.73 and a 200 day simple moving average of $5.71.
Oxford BioMedica Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Stories
- Five stocks we like better than Oxford BioMedica
- The 3 Best Blue-Chip Stocks to Buy Now
- The Drone Arms Race: From Battlefield to Balance Sheet
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Wall Street Is Backing These 3 Comeback Stocks
- How to Use the MarketBeat Excel Dividend Calculator
- Intel’s Breakout Quarter: More Than a Beat, It’s a Declaration
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
